Literature DB >> 29067754

Influence of ejection fraction on cause-specific mortality in heart failure with preserved ejection fraction.

Navkaranbir S Bajaj1, Brian Claggett1, Eldrin F Lewis1, Akshay S Desai1, James C Fang2, Eileen O'Meara3, Sanjiv J Shah4, Nancy K Sweitzer5, Jerome L Fleg6, Bertram Pitt7, Jean L Rouleau3, Peter Finn1, Marc A Pfeffer1, Scott D Solomon1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29067754      PMCID： PMC5899668          DOI： 10.1002/ejhf.1040

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  7 in total

1.  Spironolactone Metabolites in TOPCAT - New Insights into Regional Variation.

Authors:  Simon de Denus; Eileen O'Meara; Akshay S Desai; Brian Claggett; Eldrin F Lewis; Grégoire Leclair; Martin Jutras; Joël Lavoie; Scott D Solomon; Bertram Pitt; Marc A Pfeffer; Jean L Rouleau
Journal:  N Engl J Med       Date:  2017-04-27       Impact factor: 91.245

2.  Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial.

Authors:  Marc A Pfeffer; Brian Claggett; Susan F Assmann; Robin Boineau; Inder S Anand; Nadine Clausell; Akshay S Desai; Rafael Diaz; Jerome L Fleg; Ivan Gordeev; John F Heitner; Eldrin F Lewis; Eileen O'Meara; Jean-Lucien Rouleau; Jeffrey L Probstfield; Tamaz Shaburishvili; Sanjiv J Shah; Scott D Solomon; Nancy K Sweitzer; Sonja M McKinlay; Bertram Pitt
Journal:  Circulation       Date:  2014-11-18       Impact factor: 29.690

3.  Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction.

Authors:  Akshay S Desai; Eldrin F Lewis; Rebecca Li; Scott D Solomon; Susan F Assmann; Robin Boineau; Nadine Clausell; Rafael Diaz; Jerome L Fleg; Ivan Gordeev; Sonja McKinlay; Eileen O'Meara; Tamaz Shaburishvili; Bertram Pitt; Marc A Pfeffer
Journal:  Am Heart J       Date:  2011-11-08       Impact factor: 4.749

4.  Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients.

Authors:  Scott D Solomon; Nagesh Anavekar; Hicham Skali; John J V McMurray; Karl Swedberg; Salim Yusuf; Christopher B Granger; Eric L Michelson; Duolao Wang; Stuart Pocock; Marc A Pfeffer
Journal:  Circulation       Date:  2005-12-05       Impact factor: 29.690

5.  Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction.

Authors:  Scott D Solomon; Brian Claggett; Eldrin F Lewis; Akshay Desai; Inder Anand; Nancy K Sweitzer; Eileen O'Meara; Sanjiv J Shah; Sonja McKinlay; Jerome L Fleg; George Sopko; Bertram Pitt; Marc A Pfeffer
Journal:  Eur Heart J       Date:  2015-09-15       Impact factor: 29.983

6.  Spironolactone for heart failure with preserved ejection fraction.

Authors:  Bertram Pitt; Marc A Pfeffer; Susan F Assmann; Robin Boineau; Inder S Anand; Brian Claggett; Nadine Clausell; Akshay S Desai; Rafael Diaz; Jerome L Fleg; Ivan Gordeev; Brian Harty; John F Heitner; Christopher T Kenwood; Eldrin F Lewis; Eileen O'Meara; Jeffrey L Probstfield; Tamaz Shaburishvili; Sanjiv J Shah; Scott D Solomon; Nancy K Sweitzer; Song Yang; Sonja M McKinlay
Journal:  N Engl J Med       Date:  2014-04-10       Impact factor: 91.245

Review 7.  Developing therapies for heart failure with preserved ejection fraction: current state and future directions.

Authors:  Javed Butler; Gregg C Fonarow; Michael R Zile; Carolyn S Lam; Lothar Roessig; Erik B Schelbert; Sanjiv J Shah; Ali Ahmed; Robert O Bonow; John G F Cleland; Robert J Cody; Ovidiu Chioncel; Sean P Collins; Preston Dunnmon; Gerasimos Filippatos; Martin P Lefkowitz; Catherine N Marti; John J McMurray; Frank Misselwitz; Savina Nodari; Christopher O'Connor; Marc A Pfeffer; Burkert Pieske; Bertram Pitt; Giuseppe Rosano; Hani N Sabbah; Michele Senni; Scott D Solomon; Norman Stockbridge; John R Teerlink; Vasiliki V Georgiopoulou; Mihai Gheorghiade
Journal:  JACC Heart Fail       Date:  2014-04       Impact factor: 12.035
  7 in total
  3 in total

1.  Sudden Death After Hospitalization for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial).

Authors:  Muthiah Vaduganathan; Ravi B Patel; Robert J Mentz; Haris Subacius; Neal A Chatterjee; Stephen J Greene; Andrew P Ambrosy; Aldo P Maggioni; James E Udelson; Karl Swedberg; Marvin A Konstam; Christopher M O'Connor; Javed Butler; Mihai Gheorghiade; Faiez Zannad
Journal:  Am J Cardiol       Date:  2018-04-11       Impact factor: 2.778

Review 2.  Noncardiac comorbidity clustering in heart failure: an overlooked aspect with potential therapeutic door.

Authors:  Alberto Palazzuoli; Gaetano Ruocco; Edoardo Gronda
Journal:  Heart Fail Rev       Date:  2022-05       Impact factor: 4.214

3.  Extended-Release Oral Milrinone for the Treatment of Heart Failure With Preserved Ejection Fraction.

Authors:  Shane Nanayakkara; Melissa Byrne; Vivian Mak; Kaye Carter; Eliza Dean; David M Kaye
Journal:  J Am Heart Assoc       Date:  2020-06-18       Impact factor: 5.501
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.